Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up rpe was reported and averaged for each intensity stage at timepoints 0 minutes- 4 minutes (0 watts), 8 minutes-12 minutes (50 watts), 16 minutes-20 minutes (100 watts), and 24 minutes (150 watts).
Summary
This trial is studying how eating marijuana affects exercise performance. It focuses on athletes and people who exercise regularly. Researchers will look at how it impacts heart and lung function, energy use, and endurance to see if it helps or hurts performance. Cannabis, particularly its components THC and CBD, has been studied for its effects on athletic performance and recovery, with THC generally showing null or detrimental effects on exercise performance.
Eligible Conditions
- Endurance Exercise
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ rpe was reported and averaged for each intensity stage at timepoints 0 minutes- 4 minutes (0 watts), 8 minutes-12 minutes (50 watts), 16 minutes-20 minutes (100 watts), and 24 minutes (150 watts).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~rpe was reported and averaged for each intensity stage at timepoints 0 minutes- 4 minutes (0 watts), 8 minutes-12 minutes (50 watts), 16 minutes-20 minutes (100 watts), and 24 minutes (150 watts).
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Comparison of Blood Lactate Levels During a 24 Minute Graded Standard Exercise Test (50 Watts, 100 Watts, and 150 Watts) to Placebo.
Comparison of Heart Rate During a 24 Minute Graded Standard Exercise Test (50 Watts, 100 Watts, and 150 Watts) to Placebo.
Comparison of Indirect Calorimetry (VO2) During a 24 Minute Graded Standard Exercise Test (50 Watts, 100 Watts, and 150 Watts) to Placebo.
+3 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: 10 mg THCActive Control1 Intervention
Delta-9-tetrahydrocannabinol (THC) 5 milligrams (mg) in gummy form. One time, two gummies will be ingested prior to an exercise bout.
Group II: PlaceboPlacebo Group1 Intervention
Delta-9-tetrahydrocannabinol (THC) free fruit snack gummy. One time, two gummies will be ingested prior to an exercise bout.
Find a Location
Who is running the clinical trial?
Christopher BellLead Sponsor
8 Previous Clinical Trials
217 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger